The Platform for Scientific Capital Markets
BioVergence helps scientific assets move from signal to structure to market through community intelligence, AI-driven underwriting, and tokenization-ready infrastructure.
We are building the platform to identify, price, finance, and selectively productize scientific assets — from datasets, royalties, and milestones to diagnostics, peptides, and other tokenization-ready science programs.
A flourishing universe built on partnerships
We're reimagining how science moves from lab to world.
One platform. Two capital-formation lanes.
Platform infrastructure
Typed scientific assets, contributor workflows, AI-assisted diligence, and regulated issuance pathways for rights, royalties, milestones, datasets, and programs.
Community intelligence
A structured network of scouts, validators, predictors, and dataset suppliers helping BioVergence identify demand, validate evidence, and improve what gets financed and built.
Selective productization
Peptides, diagnostics, and adjacent science programs validated through community demand, protocol design, and staged capital formation before larger structured financings.
What we are advancing now
Tokenizing $100M in therapeutics assets focused on metabolic and longevity health
AI PoC, contributor workflows, typed asset intake, early pledges / pre-sale decisioning, and selective product/protocol validation campaigns.
First paid intelligence outputs, first structured issuances, and first selective launches across product and protocol programs.
Science innovation is slow. We're fixing it.
Innovations are captured as discrete IP assets — patent, data set, protocol — plus royalties and milestones.
Each IP asset is registered as a secure transactable unit allowing traceable licensing, remixing, and bundling of IP & contracts.
External players, corporates, and universities license curated bundles of interoperable IP. Trading escapes typical investment & licensing constraints.
Companies can license and use IP assets to accelerate commercialization and avoid reinventing core tech — also a source of funding.
BioVergence is unlocking remixable assets across science and engineering. Explore bioscience assets you can build with, license, and recombine.
Projects
Pipeline Projects
A living pipeline of innovation
A living pipeline of innovation
A living pipeline of innovation
From biofabrication to quantum therapeutics, BioVergence is building a pipeline of projects at the edge of deep tech and science. Every project is designed to scale, recombine, and evolve through the BioVergence ecosystem.
No red tape, no gatekeepers
No red tape, no gatekeepers
We’re reimagining how science moves from lab to world. At the heart of our platform is a recombinant asset library—powered by BIOX—that gives innovators across biotech, AI, and climate tech the tools to build, remix, and scale breakthrough solutions faster than ever.
No red tape. No gatekeepers. Just a decentralized hive of scientists, builders, and dreamers accelerating bioconvergence through open collaboration, modular assets, and community-powered innovation. Join us in unlocking the next frontier—where untapped science becomes real-world impact.
We’re reimagining how science moves from lab to world. At the heart of our platform is a recombinant asset library—powered by BIOX—that gives innovators across biotech, AI, and climate tech the tools to build, remix, and scale breakthrough solutions faster than ever.
No red tape. No gatekeepers. Just a decentralized hive of scientists, builders, and dreamers accelerating bioconvergence through open collaboration, modular assets, and community-powered innovation. Join us in unlocking the next frontier—where untapped science becomes real-world impact.
Community
Community
A community platform driving insights
A community platform driving insights
Become a part of the BioVergence ecosystem — a global network of scientists, builders, and backers collaborating across domains to launch modular innovation.
Become a part of the BioVergence ecosystem — a global network of scientists, builders, and backers collaborating across domains to launch modular innovation.
Become a part of the BioVergence ecosystem — a global network of scientists, builders, and backers collaborating across domains to launch modular innovation.
FAQ
Frequently asked questions
Frequently asked questions
Frequently asked questions
What is your tokenization process?
Where do the scientific assets come from?
Who is BioVergence for?
How do I get started?
The Platform for Scientific Capital Markets
BioVergence helps scientific assets move from signal to structure to market through community intelligence, AI-driven underwriting, and tokenization-ready infrastructure.
We are building the platform to identify, price, finance, and selectively productize scientific assets — from datasets, royalties, and milestones to diagnostics, peptides, and other tokenization-ready science programs.
A flourishing universe built on partnerships
We're reimagining how science moves from lab to world.
One platform. Two capital-formation lanes.
Platform infrastructure
Typed scientific assets, contributor workflows, AI-assisted diligence, and regulated issuance pathways for rights, royalties, milestones, datasets, and programs.
Community intelligence
A structured network of scouts, validators, predictors, and dataset suppliers helping BioVergence identify demand, validate evidence, and improve what gets financed and built.
Selective productization
Peptides, diagnostics, and adjacent science programs validated through community demand, protocol design, and staged capital formation before larger structured financings.
What we are advancing now
Tokenizing $100M in therapeutics assets focused on metabolic and longevity health
AI PoC, contributor workflows, typed asset intake, early pledges / pre-sale decisioning, and selective product/protocol validation campaigns.
First paid intelligence outputs, first structured issuances, and first selective launches across product and protocol programs.
Science innovation is slow. We're fixing it.
Innovations are captured as discrete IP assets — patent, data set, protocol — plus royalties and milestones.
Each IP asset is registered as a secure transactable unit allowing traceable licensing, remixing, and bundling of IP & contracts.
External players, corporates, and universities license curated bundles of interoperable IP. Trading escapes typical investment & licensing constraints.
Companies can license and use IP assets to accelerate commercialization and avoid reinventing core tech — also a source of funding.
BioVergence is unlocking remixable assets across science and engineering. Explore bioscience assets you can build with, license, and recombine.
Projects
Pipeline Projects
A living pipeline of innovation
A living pipeline of innovation
A living pipeline of innovation
From biofabrication to quantum therapeutics, BioVergence is building a pipeline of projects at the edge of deep tech and science. Every project is designed to scale, recombine, and evolve through the BioVergence ecosystem.
No red tape, no gatekeepers
No red tape, no gatekeepers
We’re reimagining how science moves from lab to world. At the heart of our platform is a recombinant asset library—powered by BIOX—that gives innovators across biotech, AI, and climate tech the tools to build, remix, and scale breakthrough solutions faster than ever.
No red tape. No gatekeepers. Just a decentralized hive of scientists, builders, and dreamers accelerating bioconvergence through open collaboration, modular assets, and community-powered innovation. Join us in unlocking the next frontier—where untapped science becomes real-world impact.
We’re reimagining how science moves from lab to world. At the heart of our platform is a recombinant asset library—powered by BIOX—that gives innovators across biotech, AI, and climate tech the tools to build, remix, and scale breakthrough solutions faster than ever.
No red tape. No gatekeepers. Just a decentralized hive of scientists, builders, and dreamers accelerating bioconvergence through open collaboration, modular assets, and community-powered innovation. Join us in unlocking the next frontier—where untapped science becomes real-world impact.
Community
Community
A community platform driving insights
A community platform driving insights
Become a part of the BioVergence ecosystem — a global network of scientists, builders, and backers collaborating across domains to launch modular innovation.
Become a part of the BioVergence ecosystem — a global network of scientists, builders, and backers collaborating across domains to launch modular innovation.
Become a part of the BioVergence ecosystem — a global network of scientists, builders, and backers collaborating across domains to launch modular innovation.
FAQ